Skip To The Main Content
Section Banner
Support OREF

Corporate Associates

OREF funds both investigator- and agenda-driven research. Agenda-driven topics are focused on a specific area of research that is particularly relevant to the field. Within its agenda-driven portfolio, OREF’s Collaborative Research Agenda (CRA) program takes a multi-partner approach to funding research. Through the CRA, OREF brings together researchers, orthopaedic surgeons, industry and other orthopaedic organizations to identify and fund research which addresses current areas of need for basic and translational research.

Current agenda-driven programs (including CRA topics) include:

  • Patient Safety
  • Trauma (CRA)
  • Youth Sports Injuries
  • Hip and Knee Arthoplasty Infection (CRA)
  • Bone Infection
  • Arthritis
  • Stem Cells
Click here to make on an online contribution in support of OREF's mission.

For more information about OREF's Corporate Associates program, please contact the OREF Strategic Partnerships team:
Carol Wargo, MA, CAE, CFRE
Vice President, Strategic Partnerships
(847) 430-5112

Thomas Heneghan
Corporate Relations Officer
(847) 430-5103


Corporate Associates


$200,000 to $499,999
  Arthrex
National Stem Cell Foundation
Zimmer Biomet

$100,000 to $199,999
The Aircast Foundation
DePuy Synthes
Musculoskeletal Transplant Foundation
Stryker
Wright Medical

$50,000 to $99,999
Medacta International
Pacira Pharmaceuticals

$10,000 to $49,999

Cigna Foundation
Current Concepts in Joint
     Replacement (CCJR)
Exactech, Inc.

$2,500 to $9,999

Flexion Therapeuics
Integra Foundation
Kinamed, Inc.
Maine Orthopaedic Review Course
Venel